Human Papillomavirus

A recent study investigated demographic and other factors that impact parents’ intention to have their teenagers vaccinated for human papillomavirus (HPV).

The Centers for Disease Control and Prevention has released new recommendations for the serogroup B meningococcal vaccination series.

The impact of receiving fewer than 3 doses of the human papillomavirus vaccine on the prevention of genital warts is unknown. A recent study compared rates of genital warts seen with 0, 1, 2, or 3 doses of...

In a recent study, researchers assessed the potential effects of HPV vaccination on rates of oral HPV infections. For study details, including population-level effectiveness of the HPV vaccination,

A report from the CDC’s National Center for Health Statistics provides estimates for the prevalence of oral and genital human papillomavirus infection in the US.

In a recent study, researchers compared long-term effects and clinical outcomes associated with various dosages of the human papillomavirus vaccine.

A recent study sought to determine the best methods for providers to use to increase the number of HPV vaccinations in adolescents between 11 and 12.

A study sought to determine if a lower dosage of radiation could effectively treat HPV-associated oropharyngeal squamous cell carcinoma while reducing side effect.

The CDC has updated its 2014 and 2015 guidelines on vaccination against the human papillomavirus, focusing on individuals aged 9 to 14 years.

A review of studies led to the new recommendation, which comes following a vote from the Advisory Committee on Immunization Practices.